Introduction
============

Many vascular surgery procedures are performed in high-risk patients every day. The incidence of cardiac complications and death after vascular surgery remains relatively high despite advanced perioperative monitoring and improvement in therapeutic management.[@b1-tcrm-14-1315]--[@b3-tcrm-14-1315] The assessment of dynamic changes of ventricular repolarization derangement may be a useful tool for predicting postoperative cardiac complications. Ventricular repolarization analysis using QT interval dispersion and QT interval duration corrected for heart rate (QTc) with a 12-lead electrocardiogram (ECG) or a Holter is rarely used in everyday practice. The relationship between intraoperative repolarization disturbances and clinical significance has not yet been studied in the vascular surgery patients.

The clinical manifestation of acquired repolarization disturbances may be quite variable: from clinically asymptomatic electrocardiographic abnormalities (clinically concealed QT interval prolongation) through ventricular ectopic beats, monomorphic or polymorphic ventricular tachycardia (such as torsade de pointes), and ventricular fibrillation to a sudden arrhythmic cardiac death.[@b4-tcrm-14-1315]--[@b6-tcrm-14-1315] Acquired repolarization disturbances may be associated with patient and/or procedure. They could be caused by ischemia, electrolyte disturbances, metabolic or endocrine disorders, adrenergic stimulation, drug side effects, or genetic predisposition.[@b7-tcrm-14-1315]--[@b16-tcrm-14-1315]

Electrophysiological mechanism of repolarization disorder results from either the induction of beats or disturbance in conduction. The proper flow of ions, as well as the function of the ion channels, is crucial for the stability of ventricular repolarization.[@b17-tcrm-14-1315] With the action of catecholamines, the sympathetic nervous system activates β-adrenergic receptors in cardiomyocytes. As a result, second messenger concentration rises (namely calcium ions and cyclic adenosine monophosphate \[cAMP\]), leading to the activation of cAMP-dependent protein kinase A (PKA) and ion channels. Activated PKA can phosphorylate a range of proteins involved in the regulation of electrical activity and contractility.[@b18-tcrm-14-1315] A diverse family of proteins is engaged in the regulation of activity of cAMP/PKA and in calcium signaling within the cells. One of them is the A-kinase anchoring proteins (AKAPs) family, which is a group of structurally heterogeneous proteins encoded by AKAP genes. Modification of both the cardiac ion channels and the structure of channel-related proteins (ie, AKAP) may induce arrhythmias.

Multiple studies have shown that AKAP10 may be associated with the regulation of the cardiac rhythm and may account for cardiac repolarization disturbances.[@b17-tcrm-14-1315]--[@b23-tcrm-14-1315] The exact molecular mechanism still needs to be elucidated. In our previous study, we showed that the AKAP10 polymorphism was associated with acquired repolarization disorders in kidney recipients during transplantation procedure.[@b24-tcrm-14-1315] In turn, clinical significance of such polymorphism with a reference to specific perioperative factors in the field of vascular surgery remains unexplored.

The aim of the present study was to assess the predisposition of functional genetic variants of AKAP10 toward acquired repolarization disorders in high-risk vascular surgery patients.

Materials and methods
=====================

A prospective observational study was conducted in the Department of Anesthesiology, Intensive Therapy and Acute Intoxications of Pomeranian Medical University in Szczecin, Poland. The study was granted permission from the local bioethical committee of Pomeranian Medical University in Szczecin, Poland. Written informed consent was obtained from all participants. The study has been registered at the [ClinicalTrials.gov](http://ClinicalTrials.gov) website (NCT03188341).

The study group consisted of 100 patients (mean age: 66±9 years), predominantly (87%) male, diagnosed with abdominal subrenal aortic aneurysm (69%) or aortoiliac occlusive disease (31%), scheduled for an elective "open" vascular surgery procedure. The patients were included in the study for 2 years. Demographic, Holter, and laboratory data were collected immediately after the operation. Genetic analysis was performed in two rounds after a adequate number of samples had been gathered, and concluded within 1 year from the operation. All performed procedures were assessed as the highest surgical risk according to the European Society of Cardiology (ESC)/European Society of Anaesthesiology guidelines.[@b25-tcrm-14-1315] Patient and procedure risks were assessed by Vascular Physiological and Operative Severity Score for the enumeration of Mortality and Morbidity (V-POSSUM) scoring system. Inclusion criteria were the following: adult patients diagnosed with abdominal subrenal aortic aneurysm or peripheral arterial disease scheduled for an elective "open" vascular surgery procedure. Exclusion criteria were the following: heart stimulation (paced rhythm), atrioventricular conduction disturbances, intraventricular conduction disturbances (defined by abnormal QRS morphology and duration \>120 ms in the standard 12-lead ECG), any prior episode of atrial fibrillation documented by the standard 12-lead ECG or ECG Holter, antiarrhythmic drug treatment (except β-blockers), taking any drugs with proarrhythmic potential (according to the Guidance for Industry E14 Clinical Evaluation of QT/QTc Interval Prolongation and Proarrhythmic Potential for Non-Antiarrhythmic Drugs available in <http://www.fda.gov/cder/guidance/index.htm>), patient general status (uncontrolled diabetes and active infection), reoperation, and emergency operations. All patients who qualified for the study underwent general and/or regional anesthesia according to a local protocol (described in detail in our previous study).[@b26-tcrm-14-1315] In the operating room, standard monitoring of vital functions was carried out, including an ECG, continuous invasive blood pressure and central venous pressure monitoring using an Infinity^®^ Delta Monitor (Draeger G, Luebeck, Germany), and in some cases (American Society of Anaesthesiology IV) advanced hemodynamic monitoring by Vigileo™ Monitor (Edwards Lifesciences, Irvine, CA, USA). Fluid therapy, ephedrine boluses (Ephedrinum Hydrochloricum WZF; Polfa, Warszawa, Poland), dobutamine (Sandoz GmbH, Kundl, Austria), and/or noradrenaline (Levonor; Polfa, Warszawa, Poland) infusion were used according to the local protocol. Acute functional changes of the cardiovascular system were defined as follows: heart rate \<50 or \>120 bpm and/or blood pressure amplitude (maximal--minimal range) \>50 mmHg for systolic pressure and/or 30 mmHg for diastolic pressure lasting longer than 10 minutes despite treatment within the first 24 hours after the beginning of the operation.[@b27-tcrm-14-1315] Metabolic monitoring consisted of electrolytes and arterial blood gas analysis of samples drawn just prior to anesthesia induction and at the end of the procedure. The following parameters were analyzed: pH, lactate, hemoglobin, hematocrit, and potassium concentration (K+), using a GEM Premier 3000 (Werfen Company, San Diego, CA, USA).

Repolarization stability was assessed by Holter ECG recording. Immediately before anesthesia, continuous electrocardiographic recording was initiated using digital Holter ECG monitor type 300-7 (Suprima System, Oxford, UK) and maintained up to 24 hours after surgical procedure. Seven electrodes were placed in standard positions (type B). Type B, which generated ECG tracings in 3 leads: V5, V1, and III at a speed of 25 mm/s and standard amplification of 1 mV/cm. After manual trace analysis, a dedicated researcher (medical doctor) performed the evaluation, which consisted of arrhythmia classification and assessment of QTc according to Bazett formula (QTc = QT/RR^1/2^). Repolarization disturbances during the surgical procedure or within the first 24-hour period were defined as at least one of the following: corrected QT interval longer than 500 ms or the maximal--minimal corrected QT interval (dispersion) longer than 65 ms, evaluated by ECG Holter recording (subgroups encoded: "repolarization disturbances present" vs "repolarization disturbances absent").

After the induction of anesthesia, 4 mL of blood was collected from all the patients into a probe with anticoagulant to enable genetic studies. Genomic DNA was isolated from peripheral blood leukocytes using the QIAamp Blood DNA Mini Kit (Qiagen, Hilden, Germany). Subsequently, we applied polymerase chain reaction (PCR) restriction fragment length polymorphism methods to investigate 1936A→G (I646V) (rs203462) AKAP10 polymorphism in the study population. Optimal PCR conditions (temperature--time profile and the number of cycles) for given primer pairs and conditions for restriction analysis of formed amplicons were identified in initial experiments. All amplifications were performed in a thermal cycler Mastercycler^®^ gradient (Eppendorf, Warsaw, Poland). The 20 μL of reacting mixture contained 40 ng of genomic DNA, PCR buffer (10 mmol/L Tris--HCl, 50 mmol/L KCl, and 0.08% Nonidet P40; MBI Fermentas, Vilnius, Lithuania), deoxynucleotide triphosphate (200 mmol/L; MBI Fermentas), magnesium chloride (1.5 mmol/L; MBI Fermentas), sense and antisense primers -- 4 pmol each (TIB Molbiol, Poznan, Poland), and 0.5 U of Taq polymerase (MBI Fermentas). Restriction fragments separated electrophoretically in a 3% agarose gel were stained with ethidium bromide. The separation was performed in a Tris/borate/EDTA buffer (0.089 mmol/L Tris, 0.089 mmol/L boric acid, and 2 mmol/L EDTA), at a temperature of 20°C and a voltage of 70 V. Restriction fragments were identified based on DNA markers (pUC Mix Marker 8; MBI Fermentas). The final stage was gel documentation using the G:BOX BioImaging System (Syngene, Cambridge, UK).

Postoperative cardiac complications were defined as acute coronary syndrome (ACS), acute cardiac failure, syncope, or sudden cardiac death (SCD) within the first 24 hours after beginning the surgical procedure. These events were diagnosed with clinical examination, ECG, laboratory tests, and echocardiography. The normal ranges of the biochemical results when considering ACS were defined as follows: troponin I: 0.01--0.2 μg/L and creatine kinase-MB: 17--35 IU/L. [Table 1](#t1-tcrm-14-1315){ref-type="table"} presents the definitions of cardiac complications.

Ventricular tachycardia was defined according to the American College of Cardiology/American Heart Association/ESC 2006 guidelines.[@b30-tcrm-14-1315] Statistical analysis was performed using STATISTICA 13.1 PL software (Statistica, Tulsa, OK, USA). The normality of the data distribution was verified using Shapiro--Wilk test. Since most quantitative variables were nonnormally distributed, nonparametric Mann--Whitney test was used for their between-group comparisons. *χ*^2^ or Fisher's exact test was used for quantitative variables, including genotypes. Multivariate logistic regression models were constructed to find independent predictors of repolarization disturbances or cardiac complications. A *p*-value \<0.05 was considered statistically significant.

The power of the study to detect an association of the AKAP10 rs203462 single-nucleotide polymorphism (SNP) with repolarization disorders recorded by Holter was estimated using PS program Version 3.0.43, given assumptions based on previous studies that the disorders ought to be present in 50% of patients and the frequency of G allele carriers in Polish population is 50%. The study sample size (n=100) was sufficient to detect with 80% probability the true effect degree of difference in frequency of Holter ECG disorders between G allele carriers and AA homozygotes measured as odds ratio (OR) equal to 0.304 or 3.289.

Ethics approval and consent to participate
------------------------------------------

The study was granted permission from the Bioethical Committee of Pomeranian Medical University in Szczecin, Poland (27.05.2008; BN-001/52/08).

Results
=======

We recruited 100 patients (aged 66±9 years, range: 44--85). The mean value of the Physiology Score V-POSSUM was 14±3. All the patients were treated with aspirin and statins; 60% of the patients were treated with β-blocker because of ischemic heart disease, heart failure, or arterial hypertension. According to the demographic and clinical data, concomitant medications were continued in the perioperative period. No patient had kidney failure in the past medical history.

The mean blood loss during the procedure was 570±250 mL. Thirty-one percent of the patients needed vasopressors or inotropes boluses/infusion for hemodynamic stabilization. The drug most commonly used was ephedrine. No patient needed prolonged ventilatory support.

The study population had the following AKAP10 gene rs203462 polymorphism distribution: AA 53%, AG 35%, and GG 12%. The distribution was in concordance with Hardy--Weinberg equilibrium (*p*=0.146).

Perioperative causes of repolarization disturbances registered by Holter
------------------------------------------------------------------------

There was no prolongation of the QTc interval nor QTc dispersion before the surgery. During the operation and within the first 24 hours, repolarization disturbances were registered in 36% of patients when defined as acquired QTc interval prolongation \>500 ms and in 31% of patients when defined as QTc interval dispersion \>65 ms. ECG Holter monitoring recorded nonsustained monomorphic tachycardia within the first 24 hours in six cases, yet it was only observed in the subgroup of patients with repolarization disturbances (*p*=0.007).

Regarding 24-hour ECG Holter records, patients were stratified into two groups depending on whether the repolarization disturbances were present or absent. [Table 2](#t2-tcrm-14-1315){ref-type="table"} compares these data.

There were no significant differences between groups regarding the type of surgery, metabolic parameters, duration of the procedure, aorta clamping time, or intraoperative blood loss. In the model of univariate logistic regression, the clinically important predictors of repolarization disturbances occurring in the 24-hour Holter ECG were the following: preoperative heart failure (OR =3.45; 95% CI =1.10--10.87; *p*=0.031) and a history of cerebral stroke (OR =3.47; 95% CI =0.99--12.13; *p*=0.048). The presence of G allele in the AKAP10 polymorphism (genotypes GG + AG) turned out to be a strong predictor of repolarization derangement in the perioperative period (OR =11.13; 95% CI =4.32--28.64; *p*\<0.0001). [Table 3](#t3-tcrm-14-1315){ref-type="table"} presents the data.

In the model of multivariate logistic regression, considering age, sex, preoperative heart failure, stroke, and V-POSSUM score, only the presence of G allele in the rs203462 AKAP10 polymorphism constitutes an independent risk factor for repolarization disturbances in the perioperative period (OR =14.35; 95% CI =4.65--44.23; *p*\<0.0001; GG + AG vs AA). Other clinical risk factors included in this model were insignificant predictors of the perioperative repolarization period disturbances (*p*\>0.1).

Clinical significance of repolarization disturbances (first 24 hours)
---------------------------------------------------------------------

The earlier-defined acute functional changes of the cardiovascular system and simultaneous repolarization disturbances occurred in 19 cases. There was no statistically significant association between them. We observed the following clinical picture: hypotension: 10 patients, bradycardia: three cases, and tachycardia: six patients. Acute hemodynamic decompensation that occurred during the operation was observed in 17 cases, and one that occurred within 24 hours after the operation was observed in only two cases. The acute functional changes of the cardiovascular system were observed at the following times: induction to general anesthesia (six patients), declamping of aorta (11 patients), and hypotension and episode of atrial fibrillation after operation (two patients).

After the surgical procedure, clinical significance of complications was assessed by clinical examination, ECG, laboratory tests, and echocardiography. Postoperative cardiac complications were diagnosed in five cases. ACS was confirmed in one case, and decompensation of chronic heart failure (CHF) was diagnosed in three cases. One patient died because of severe ventricular arrhythmia (SCD). Both ACS and SCD occurred in the subgroup that was free of repolarization disturbances. In turn, cases of decompensated CHF belonged to the repolarization disturbances subgroup. In all the above five cases, the first manifestation was hypotension observed after clamp release during abdominal aortic aneurysm procedures.

None of the genetic variants of the *AKAP10* polymorphism turned out to be a predictor of acute functional changes of the cardiovascular system.

Discussion
==========

The frequency of repolarization abnormalities is elevated in high-risk vascular patients. Its clinical importance and association with postoperative cardiac complications remain to be elucidated. In our study, ventricular repolarization disturbances were observed in almost half of the vascular surgery patients. The only factor independently associated with the occurrence of repolarization abnormalities in the 24-hour ECG Holter monitoring is the presence of G allele of the rs203462 polymorphism of *AKAP10*. Despite the presence of observed repolarization disturbances, none were clinically significant (ie, causing any clinical symptoms). The main result of the study was to prove the predisposition of functional genetic variants of *AKAP10* toward clinically benign acquired repolarization disorders (QTc interval or dispersion prolongation) in high-risk vascular surgery patients. According to our knowledge, there are no similar studies available in the literature.

We defined limit values of repolarization disturbances (QTc \>500 ms and QT dispersion \>65 ms) based on our previous observations since there are no absolute QTc intervals or dispersion thresholds above which ventricular arrhythmia must occur.[@b24-tcrm-14-1315],[@b26-tcrm-14-1315] Botchorishvili et al concluded that QT dispersion longer than 70 ms is considered a risk factor of ventricular arrhythmia development in vascular surgery patients.[@b31-tcrm-14-1315] Sahu et al concluded that QT dispersion in normal subjects should be ≤50 ms and that QTc dispersion \>60 ms was associated with a twofold increase in SCD.[@b32-tcrm-14-1315] We noticed repolarization disturbances in 46 patients (46%). No polymorphic ventricular tachycardia was detected. We observed paroxysmal monomorphic ventricular tachycardia in six cases. Episodes recorded by ECG Holter were very short and "clinically concealed" (as without hemodynamic dec-ompensation). This observation cannot be explained by the simultaneous action of drugs. Masutani observed serious arrhythmias, respectively, in 10% and 11%, intraoperatively and postoperatively, among abdominal surgery patients.[@b33-tcrm-14-1315] They showed the following risk factors: advanced age, ventricular extrasystoles, and untreated hypotension. No similar data exist for vascular surgery.

Several previous studies have analyzed a relationship between *AKAP10* gene polymorphisms and cardiac repolarization disturbances among kidney transplant recipients and in newborns.[@b24-tcrm-14-1315],[@b34-tcrm-14-1315] The result of the kidney transplantation study indicates that the presence of allele G of the rs203462 *AKAP10* polymorphism may predispose to prolongation of the QT interval when compared to allele A carriers.[@b24-tcrm-14-1315] Łoniewska et al observed similar results in the newborns.[@b34-tcrm-14-1315] The QT interval in GG homozygotes of AKAP10 was significantly longer (but still in range) when compared to A allele carriers (AG + AA). In both studies, repolarization disturbances did not provoke clinically significant arrhythmia or hemodynamic failure. Some authors believe that the genetic variant of AKAP10 is expressed as truncated forms unable to anchor PKA.[@b18-tcrm-14-1315],[@b21-tcrm-14-1315] Such a situation may lead to cardiac arrhythmias and SCD. The findings from studies on humans and mice have similar conclusions.[@b17-tcrm-14-1315],[@b21-tcrm-14-1315] On the other hand, an SNP 1936A→G (I646V) (rs203462) in D-AKAP2 (a product of AKAP10 gene, which can interact with PKA) is recognized as a cause of increased affinity of cAMP for PKA. It was found to correlate with a shorter PR interval, tachycardia, and abnormal heart rate variability -- well-defined causes of SCD.[@b17-tcrm-14-1315],[@b18-tcrm-14-1315]

Why some repolarization disturbances are clinically concealed or significant. The initiation of arrhythmia has multifactorial etiology. Although QTc interval or dispersion prolongation is almost always required to develop ventricular arrhythmia, it is not sufficient to trigger an arrhythmic episode.[@b6-tcrm-14-1315] Many acquired factors may sustain tachyarrhythmia, leading to clinical features such as acute hemodynamic decompensation during ACS, acute circulatory failure, severe arrhythmias, syncope, and SCD. In the case of temporary short-acting triggering factors, ventricular arrhythmia may be inconstant and clinically concealed. Our results support this theory. Although 46% of our patients recorded repolarization disturbances, none have resulted in acute cardiac complications. Even though repolarization disturbances in perioperative Holter monitoring and acute functional changes of cardiovascular system were present at the same time in 19 patients, there were no statistically significant associations between them. Moreover, we have found that if the reason for QTc prolongation or QTc dispersion was the AKAP10 polymorphism, it was clinically silent. This supports the theory that in the case of induction of arrhythmia, clinical factors are more important than genetic predisposition. In contrast, Kukla et al have analyzed which of the electrocardiographic parameters indicate worse evolution in patients with acquired long QT syndrome and torsade de pointes.[@b35-tcrm-14-1315] They defined values, which could predict benign evolution: slower ventricular rate during arrhythmia (\<220 bpm) and shorter episodes \<20 beats. In our population, we observed \<20 ventricular beats during ventricular arrhythmia. It may explain why our repolarization disturbances were "concealed." However, this finding shows that a continuous ECG recording is essential during and after the procedure because potentially rapid management and initiation of treatment may prevent the persistence of the arrhythmia. Therefore, factors leading to the acquired QT interval prolongation should be avoided, namely bradycardia, ion imbalance (hypokalemia, hypomagnesemia, and hypocalcemia), some drugs, acidosis, hypothermia, increased sympathetic activation, and intensive fluctuations in the tone of the autonomic nervous system.[@b36-tcrm-14-1315]

The results of our study indicate that the ECG Holter monitoring is a good tool to record repolarization disturbances present in high-risk vascular surgery patients. Despite recorded repolarization abnormalities, none of them caused acute cardiac complications within the first 24 hours after the surgical procedure. Several studies concluded that repolarization disturbances defined as QTc interval prolongation are seen during the early phase of myocardium ischemia and could be considered a risk factor.[@b8-tcrm-14-1315] Despite some authors suggest utility of perioperative QTc assessment, it is not a routine management. Up until now, preoperative risk assessment encompasses clinical risk prediction, biochemical risk markers, and risk of procedure (surgery and anesthesia).[@b1-tcrm-14-1315],[@b36-tcrm-14-1315]

This study had some important limitations. First, we assessed our cohort as at high risk based on clinical risk factors only. Second, we did not study cardiac ischemia based on ST segment depression detected by electrocardiographic cardiac Holter monitoring. Third, considering potential risk factors for the occurrence of repolarization disturbances, we did not analyze their elements separately due to a low number of patients.

Conclusion
==========

Our study showed that the repolarization disturbances assessed by acquired prolongation of the QTc interval and QTc dispersion were common in vascular surgery patients during the perioperative period. ECG Holter monitoring was a useful tool for the detection of ventricular repolarization abnormalities. The role of genetic variants of AKAP10 was important in diagnosing predisposition for acquired ventricular repolarization disturbances. When the QTc interval prolongation or QTc dispersion was associated with AKAP10 polymorphism, it may remain clinically silent.
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###### 

Definitions of cardiac complications

  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Term                      Definition                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      Reference
  ------------------------- ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ---------------------
  Acute coronary syndrome   The myocardial infarction (MI) criteria were based on clinical history, findings on the electrocardiogram (ECG), and enzyme measurements in blood. MI was diagnosed by the presence of one of the following factors: -- ECG showing unequivocal pathological Q waves and/or ST segment elevation or depression in serial recordings; or\                                                                                                                                                                                                                                                                                                        [@b28-tcrm-14-1315]
                            -- the history of typical or atypical angina pectoris, together with equivocal changes in the ECG and elevated enzymes; or\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     
                            -- the history of typical angina pectoris and elevated enzymes with no changes in the ECG                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       

  Acute heart failure       New onset or decompensated chronic heart failure defined as a clinical syndrome in which patients have the following features: symptoms typical of heart failure (breathlessness at rest or on exercise, fatigue, tiredness, and ankle swelling) and signs typical of heart failure (tachycardia, tachypnea, pulmonary rales, pleural effusion, raised jugular venous pressure, peripheral edema, and hepatomegaly) and objective evidence of a structural or functional abnormality of the heart at rest (cardiomegaly, third heart sound, cardiac murmurs, abnormality on the echocardiogram, and raised natriuretic peptide concentration)   [@b29-tcrm-14-1315]

  Syncope                   Sudden loss of consciousness with loss of postural tone, not related to anesthesia, with spontaneous recovery as reported by the patient or observer. Patient may experience syncope when supine                                                                                                                                                                                                                                                                                                                                                                                                                                                [@b30-tcrm-14-1315]

  Sudden cardiac death      Death from an unexpected circulatory arrest, usually due to a cardiac arrhythmia occurring within an hour of the onset of symptoms                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              [@b30-tcrm-14-1315]
  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

###### 

Data of the study group stratified according to repolarization disturbances in Holter records

  Variables                                                                      Repolarization disturbances present (n=46)   Repolarization disturbances absent (n=54)   *p*-value
  ------------------------------------------------------------------------------ -------------------------------------------- ------------------------------------------- -----------
  Age (years)                                                                    66±9.9                                       66±8.9                                      0.46
  BMI                                                                            26.19±3.7                                    26.07±3.6                                   0.90
  EF (%)                                                                         50±9                                         53±9                                        0.04
  V-POSSUM score                                                                 14.95±3.02                                   14.22±3.47                                  0.004
  Mean HR (beats/min)                                                            77±13                                        74±15                                       0.16
  SBP range (mmHg)                                                               77±22                                        73±28                                       0.25
  DBP range (mmHg)                                                               33±13                                        32±13                                       0.63
  pH                                                                             7.33±0.04                                    7.34±0.04                                   0.23
  Lactate (mmol/L)                                                               1.30±0.56                                    1.25±0.64                                   0.42
  Final K+ (mmol/L)                                                              3.81±0.33                                    3.81±0.38                                   0.93
  Final Hb (g/dL)                                                                11.46±1.21                                   11.12±1.24                                  0.17
  Final Hct (%)                                                                  29.93±1.89                                   30.66±2.32                                  0.09
  Duration of procedure (minutes)                                                184±15                                       186±12                                      0.50
  Aorta clamping time (minutes)[\*\*](#tfn3-tcrm-14-1315){ref-type="table-fn"}   39±13                                        39±14                                       0.99
  Intraoperative blood loss (mL)                                                 442±120                                      452±152                                     0.70
  Male sex                                                                       42 (91)                                      45 (83)                                     0.37
  IHD                                                                            31 (57)                                      24 (52)                                     0.68
  MI                                                                             12 (26)                                      13 (24)                                     0.82
  CHF                                                                            12 (26)                                      5 (9)                                       0.03
  DM                                                                             10 (21)                                      7 (12)                                      0.29
  HA                                                                             13 (28)                                      18 (33)                                     0.66
  Dyslipidemia                                                                   11 (23)                                      8 (14)                                      0.30
  History of smoking                                                             23 (50)                                      24 (44)                                     0.68
  ASA IV                                                                         5 (10)                                       3 (5)                                       0.46
  Stroke                                                                         10 (21)                                      4 (7)                                       0.04
  AA[\*](#tfn2-tcrm-14-1315){ref-type="table-fn"}                                42 (79)                                      11 (21)                                     
  AG[\*](#tfn2-tcrm-14-1315){ref-type="table-fn"}                                9 (26)                                       26 (74)                                     \<0.01
  GG[\*](#tfn2-tcrm-14-1315){ref-type="table-fn"}                                3 (25)                                       9 (75)                                      
  Aortoiliac occlusive disease                                                   11 (35)                                      20 (65)                                     0.19
  Abdominal subrenal aortic aneurysm                                             35 (51)                                      34 (49)                                     
  Catecholamine support used                                                     14 (45)                                      17 (55)                                     1.0
  Without catecholamine support                                                  32 (46)                                      37 (54)                                     
  Acute changes of cardiovascular system present                                 19 (51)                                      18 (49)                                     0.533
  Acute changes of cardiovascular system absent                                  27 (43)                                      36 (57)                                     

**Notes:** Values are mean ± SD or n (%).

Genotypes of *AKAP10* polymorphism,

applied for abdominal subrenal aortic aneurysm repair only.

**Abbreviations:** *AKAP10*, A-kinase anchoring protein 10; ASA, American Society of Anaesthesiology; BMI, body mass index; CHF, congestive heart failure; DBP, diastolic blood pressure; DM, diabetes mellitus; EF, ejection fraction of the left ventricle; HA, arterial hypertension; Hb, hemoglobin; Hct, hematocrit; HR, heart rate; IHD, ischemic heart disease; MI, myocardial infarction in the past history; n, number of patients; SBP, systolic blood pressure; V-POSSUM, Vascular Physiological and Operative Severity Score for the enumeration of Mortality and Morbidity.

###### 

Association of *AKAP10* (rs203462) gene polymorphism with repolarization disturbances

  Compared genotypes or alleles   Odds ratio   95% CI range   *p*-value
  ------------------------------- ------------ -------------- -----------
  GG + AG vs AA                   11.13        4.38--28.31    \<0.0001
  GG vs AG + AA                   4.13         1.04--16.33    0.031
  GG vs AA                        11.45        2.64--49.60    0.0002
  G vs A                          5.68         2.87--11.23    \<0.0001
  AG vs AA                        11.03        4.02--30.21    \<0.0001
  GG vs AG                        1.03         0.22--4.70     0.960

**Abbreviation:** *AKAP10*, A-kinase anchoring protein 10.
